JP2024514112A5 - - Google Patents
Info
- Publication number
- JP2024514112A5 JP2024514112A5 JP2023561181A JP2023561181A JP2024514112A5 JP 2024514112 A5 JP2024514112 A5 JP 2024514112A5 JP 2023561181 A JP2023561181 A JP 2023561181A JP 2023561181 A JP2023561181 A JP 2023561181A JP 2024514112 A5 JP2024514112 A5 JP 2024514112A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- administered
- pharmaceutically acceptable
- acceptable salt
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163171461P | 2021-04-06 | 2021-04-06 | |
| US63/171,461 | 2021-04-06 | ||
| PCT/US2022/023496 WO2022216719A1 (en) | 2021-04-06 | 2022-04-05 | Combination therapy with belvarafenib and cobimetinib or with belvarafenib, cobimetinib, and atezolizumab |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514112A JP2024514112A (ja) | 2024-03-28 |
| JP2024514112A5 true JP2024514112A5 (enExample) | 2025-04-09 |
Family
ID=81387274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023561181A Pending JP2024514112A (ja) | 2021-04-06 | 2022-04-05 | ベルバラフェニブおよびコビメチニブを用いた併用療法、またはベルバラフェニブ、コビメチニブおよびアテゾリズマブを用いた併用療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240366609A1 (enExample) |
| EP (1) | EP4319749A1 (enExample) |
| JP (1) | JP2024514112A (enExample) |
| KR (1) | KR20230165795A (enExample) |
| CN (1) | CN117561062A (enExample) |
| TW (1) | TW202304438A (enExample) |
| WO (1) | WO2022216719A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117940130A (zh) * | 2021-03-09 | 2024-04-26 | 基因泰克公司 | 用于脑癌治疗的贝伐拉非尼 |
| CN117202897A (zh) * | 2021-04-09 | 2023-12-08 | 基因泰克公司 | 使用raf抑制剂和pd-1轴抑制剂的组合疗法 |
| CN119606963B (zh) * | 2025-02-13 | 2025-07-18 | 中国农业大学 | 一种有效清除衰老肠细胞的药物及其在治疗肠道炎症病症中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ567140A (en) | 2005-10-07 | 2011-09-30 | Exelixis Inc | Azetidines as MEK inhibitors for the treatment of proliferative diseases |
| SG11201402765TA (en) | 2011-12-30 | 2014-06-27 | Hanmi Pharm Ind Co Ltd | THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES |
| DK2884979T3 (da) | 2012-08-17 | 2019-09-02 | Hoffmann La Roche | Kombinationsbehandlinger mod melanom omfattende indgivelse af cobimetinib og vemurafenib |
| SI2909188T1 (en) | 2012-10-12 | 2018-07-31 | Exelixis, Inc. | A novel process for the manufacture of compounds for use in the treatment of cancer |
| WO2016115376A1 (en) * | 2015-01-14 | 2016-07-21 | The Regents Of The University Of California | Detection and treatment of double drug resistant melanomas |
| WO2017165491A1 (en) * | 2016-03-24 | 2017-09-28 | Millennium Pharmaceuticals, Inc. | Use of a pd-1 antagonist and a raf inhibitor in the treatment of cancer |
| CN111051535A (zh) * | 2017-06-13 | 2020-04-21 | 英国肿瘤有限公司 | 用于测定患有增生疾病的患者对使用靶向pd1/pd-l1路径的组分的药剂的治疗的敏感性的方法 |
| KR102811888B1 (ko) * | 2017-09-08 | 2025-05-27 | 에프. 호프만-라 로슈 아게 | 암의 진단 및 치료 방법 |
| MX2021013222A (es) * | 2019-05-03 | 2022-01-06 | Genentech Inc | Metodos para tratar el cancer con un anticuerpo anti-pd-l1. |
-
2022
- 2022-04-05 CN CN202280027201.3A patent/CN117561062A/zh active Pending
- 2022-04-05 WO PCT/US2022/023496 patent/WO2022216719A1/en not_active Ceased
- 2022-04-05 US US18/554,041 patent/US20240366609A1/en active Pending
- 2022-04-05 EP EP22719142.6A patent/EP4319749A1/en not_active Withdrawn
- 2022-04-05 JP JP2023561181A patent/JP2024514112A/ja active Pending
- 2022-04-05 KR KR1020237036682A patent/KR20230165795A/ko active Pending
- 2022-04-06 TW TW111113112A patent/TW202304438A/zh unknown